| Year |
Citation |
Score |
| 2022 |
Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, St James S, Zanzonico PB. Reply LTE, Single time point tumour dosimetry assuming normal distribution of tumour kinetics. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35273095 DOI: 10.2967/jnumed.121.263717 |
0.569 |
|
| 2021 |
Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, Zimmerman BE. Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 62: 3S-11S. PMID 34857621 DOI: 10.2967/jnumed.121.262749 |
0.628 |
|
| 2021 |
Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 62: 12S-22S. PMID 34857617 DOI: 10.2967/jnumed.121.262750 |
0.677 |
|
| 2020 |
Divgi C, Carrasquillo JA, Meredith R, Seo Y, Frey EC, Bolch WE, Zimmerman BE, Akabani G, Jacobson DA, Brown B, Davern SM, Hobbs RF, Humm J, Moros EG, Morse D, ... ... Zanzonico P, et al. Overcoming Barriers to Radiopharmaceutical Therapy: An Overview from the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy (RPT). International Journal of Radiation Oncology, Biology, Physics. PMID 33309909 DOI: 10.1016/j.ijrobp.2020.12.002 |
0.633 |
|
| 2020 |
Roncali E, Capala J, Benedict SH, Akabani G, Bednarz B, Bhadrasain V, Bolch WE, Buchsbaum J, Clarke BN, Coleman N, Dewaraja YK, Frey EC, Ghaly M, Grudzinski J, Hobbs RF, ... ... Zanzonico PB, et al. Overview of the First NRG-NCI Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy (RPT). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33277396 DOI: 10.2967/jnumed.120.255547 |
0.607 |
|
| 2020 |
Santich BH, Cheal SM, Ahmed M, McDevitt MR, Ouerfelli O, Yang G, Veach D, Fung EK, Patel M, Burnes Vargas D, Malik AA, Guo H, Zanzonico PB, Monette S, Michel AO, et al. A Self-Assembling and DisAssembling (SADA) bispecific antibody (BsAb) platform for curative 2-step pre-targeted radioimmunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32958698 DOI: 10.1158/1078-0432.Ccr-20-2150 |
0.352 |
|
| 2020 |
Frost GR, Longo V, Li T, Jonas LA, Judenhofer M, Cherry S, Koutcher J, Lekaye C, Zanzonico P, Li YM. Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer's disease mouse model. Scientific Reports. 10: 10379. PMID 32587315 DOI: 10.1038/S41598-020-67284-Z |
0.306 |
|
| 2020 |
Dunphy MP, Pressl C, Pillarsetty N, Grkovski M, Modi S, Jhaveri K, Norton L, Beattie BJ, Zanzonico PB, Zatorska D, Taldone T, Ochiana SO, Uddin MM, Burnazi EM, Lyashchenko SK, et al. First-in-Human Trial of Epichaperome-Targeted Positron Emission Tomography in Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32366671 DOI: 10.1158/1078-0432.Ccr-19-3704 |
0.406 |
|
| 2020 |
Krebs S, Veach DR, Carter LM, Grkovski M, Fornier M, Mauro MJ, Voss MH, Danila DC, Burnazi E, Null M, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Weber WA, et al. First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32169913 DOI: 10.2967/Jnumed.119.234864 |
0.396 |
|
| 2020 |
Zhang X, Chen F, Turker MZ, Ma K, Zanzonico P, Gallazzi F, Shah MA, Prater AR, Wiesner U, Bradbury MS, McDevitt MR, Quinn TP. Targeted melanoma radiotherapy using ultrasmall Lu-labeled α-melanocyte stimulating hormone-functionalized core-shell silica nanoparticles. Biomaterials. 241: 119858. PMID 32120314 DOI: 10.1016/J.Biomaterials.2020.119858 |
0.378 |
|
| 2020 |
Urbanska AM, Khanin R, Alidori S, Wong S, Mello BP, Almeida BA, Chen F, Ma K, Turker MZ, Korontsvit T, Scheinberg DA, Zanzonico PB, Wiesner U, Bradbury MS, Quinn TP, et al. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles. Cancer Biotherapy & Radiopharmaceuticals. PMID 32013538 DOI: 10.1089/Cbr.2019.3150 |
0.33 |
|
| 2020 |
Quinn BM, Gao Y, Mahmood U, Pandit-Taskar N, Behr G, Zanzonico P, Dauer LT. Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies. Bmc Medical Imaging. 20: 9. PMID 31996149 DOI: 10.1186/S12880-020-0415-4 |
0.308 |
|
| 2020 |
Michaud L, Beattie BJ, Akhurst T, Dunphy M, Zanzonico P, Finn R, Mauguen A, Schöder H, Weber WA, Lassman AB, Blasberg R. Correction to: F-Fluciclovine (F-FACBC) PET imaging of recurrent brain tumors. European Journal of Nuclear Medicine and Molecular Imaging. 47: 4. PMID 31492997 DOI: 10.1007/S00259-019-04514-1 |
0.338 |
|
| 2019 |
Cheal SM, Patel M, Yang G, Veach DR, Xu H, Guo HF, Zanzonico PB, Axworthy DB, Cheung NK, Ouerfelli O, Larson SM. A N-acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic Index DOTA-Hapten Pretargeted Radioimmunotherapy. Bioconjugate Chemistry. PMID 31891487 DOI: 10.1021/Acs.Bioconjchem.9B00736 |
0.321 |
|
| 2019 |
Grkovski M, Kohutek ZA, Schöder H, Brennan CW, Tabar VS, Gutin PH, Zhang Z, Young RJ, Beattie BJ, Zanzonico PB, Huse JT, Rosenblum MK, Blasberg RG, Humm JL, Beal K. F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31865407 DOI: 10.1007/S00259-019-04628-6 |
0.386 |
|
| 2019 |
Chen F, Madajewski B, Ma K, Karassawa Zanoni D, Stambuk H, Turker MZ, Monette S, Zhang L, Yoo B, Chen P, Meester RJC, de Jonge S, Montero P, Phillips E, Quinn TP, ... ... Zanzonico P, et al. Molecular phenotyping and image-guided surgical treatment of melanoma using spectrally distinct ultrasmall core-shell silica nanoparticles. Science Advances. 5: eaax5208. PMID 31840066 DOI: 10.1126/Sciadv.Aax5208 |
0.333 |
|
| 2019 |
Chen F, Ma K, Zhang L, Madajewski B, Turker MZ, Gallazzi F, Cruickshank K, Zhang X, Jenjitranant P, Touijer KA, Quinn TP, Zanzonico PB, Wiesner UB, Bradbury MS. Ultrasmall Renally-clearable Silica Nanoparticles Target Prostate Cancer. Acs Applied Materials & Interfaces. PMID 31675204 DOI: 10.1021/Acsami.9B15195 |
0.313 |
|
| 2019 |
Pillarsetty N, Jhaveri K, Taldone T, Caldas-Lopes E, Punzalan B, Joshi S, Bolaender A, Uddin MM, Rodina A, Yan P, Ku A, Ku T, Shah SK, Lyashchenko S, Burnazi E, ... ... Zanzonico P, et al. Paradigms for Precision Medicine in Epichaperome Cancer Therapy. Cancer Cell. PMID 31668946 DOI: 10.1016/J.Ccell.2019.09.007 |
0.338 |
|
| 2019 |
Juthani R, Madajewski B, Yoo B, Zhang L, Chen PM, Chen F, Turker MZ, Ma K, Overholtzer M, Longo VA, Carlin S, Aragon-Sanabria V, Huse JT, Gonen M, Zanzonico PB, et al. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31515460 DOI: 10.1158/1078-0432.Ccr-19-1834 |
0.305 |
|
| 2019 |
Michaud L, Beattie BJ, Akhurst T, Dunphy M, Zanzonico P, Finn R, Mauguen A, Schöder H, Weber WA, Lassman AB, Blasberg R. F-Fluciclovine (F-FACBC) PET imaging of recurrent brain tumors. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31418054 DOI: 10.1007/S00259-019-04433-1 |
0.385 |
|
| 2019 |
Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, Zhang Z, Lyashchenko SK, Vietri SM, Fung AM, Pentlow KS, Carrasquillo JA, Lewis JS, Larson SM, Cheung NV, et al. Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31405921 DOI: 10.2967/Jnumed.118.219576 |
0.366 |
|
| 2019 |
Carter LM, Crawford TM, Sato T, Furuta T, Choi C, Kim CH, Brown JL, Bolch WE, Zanzonico PB, Lewis JS. PARaDIM - A PHITS-based Monte Carlo tool for internal dosimetry with tetrahedral mesh computational phantoms. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31201251 DOI: 10.2967/Jnumed.119.229013 |
0.307 |
|
| 2019 |
O'Donoghue JA, Danila DC, Pandit-Taskar N, Beylergil V, Cheal SM, Fleming SE, Fox JJ, Ruan S, Zanzonico PB, Ragupathi G, Lyashchenko SK, Williams SP, Scher HI, Fine BM, Humm JL, et al. Pharmacokinetics and Biodistribution of [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients. Molecular Pharmaceutics. PMID 31117485 DOI: 10.1021/Acs.Molpharmaceut.9B00326 |
0.39 |
|
| 2019 |
Bailey K, Pandit-Taskar N, Humm JL, Zanzonico P, Gilheeney S, Cheung NV, Kramer K. Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes. Journal of Neuro-Oncology. PMID 30879172 DOI: 10.1007/S11060-019-03139-6 |
0.326 |
|
| 2019 |
Zanzonico PB. Benefits and Risks in Medical Imaging. Health Physics. 116: 135-137. PMID 30585953 DOI: 10.1097/Hp.0000000000001038 |
0.304 |
|
| 2019 |
Kramer K, Pandit-Taskar N, Donzelli M, Wolden SL, Zanzonico P, Humm J, Haque S, Souweidane MM, Lewis J, Lyashchenko SK, Larson SM, Cheung NV. Intraventricular radioimmunotherapy targeting B7H3 for CNS malignancies. Journal of Clinical Oncology. 37: e13592-e13592. DOI: 10.1200/Jco.2019.37.15_Suppl.E13592 |
0.363 |
|
| 2019 |
Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Zanzonico P, Donzelli M, Lyashchenko SK, Haque S, Thakur SB, Cheung NV, Larson SM, Dunkel IJ. A phase I study of convection-enhanced delivery of 124I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma: An update with dose-response assessment. Journal of Clinical Oncology. 37: 2008-2008. DOI: 10.1200/Jco.2019.37.15_Suppl.2008 |
0.315 |
|
| 2019 |
Bailey K, Pandit-Taskar N, Humm J, Zanzonico P, Gilheeney S, Cheung N, Kramer K. Ther-24. Targeted Radioimmunotherapy For Embryonal Tumor With Multilayered Rosettes Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.229 |
0.353 |
|
| 2018 |
Cheal SM, Xu H, Guo HF, Patel M, Punzalan B, Fung EK, Lee SG, Bell M, Singh M, Jungbluth AA, Zanzonico PB, Piersigilli A, Larson SM, Cheung NV. Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma. Theranostics. 8: 5106-5125. PMID 30429889 DOI: 10.7150/Thno.26585 |
0.419 |
|
| 2018 |
Chen F, Zhang X, Ma K, Madajewski B, Benezra M, Zhang L, Phillips E, Turker MZ, Gallazzi F, Penate-Medina O, Overholtzer M, Pauliah M, Gonen M, Zanzonico P, Wiesner U, et al. Correction to Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging. Acs Applied Materials & Interfaces. PMID 30360123 DOI: 10.1021/Acsami.8B16671 |
0.309 |
|
| 2018 |
Chen F, Ma K, Madajewski B, Zhuang L, Zhang L, Rickert K, Marelli M, Yoo B, Turker MZ, Overholtzer M, Quinn TP, Gonen M, Zanzonico P, Tuesca A, Bowen MA, et al. Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. Nature Communications. 9: 4141. PMID 30297810 DOI: 10.1038/S41467-018-06271-5 |
0.358 |
|
| 2018 |
Moroz MA, Zanzonico P, Lee JT, Ponomarev V. Ex Vivo Radiolabeling and In Vivo PET Imaging of T Cells Expressing Nuclear Reporter Genes. Methods in Molecular Biology (Clifton, N.J.). 1790: 153-163. PMID 29858790 DOI: 10.1007/978-1-4939-7860-1_12 |
0.363 |
|
| 2018 |
Cheal SM, Ruan S, Veach DR, Longo VA, Punzalan BJ, Wu J, Fung EK, Kelly MP, Kirshner JR, Giurleo JT, Ehrlich G, Han AQ, Thurston G, Olson WC, Zanzonico PB, et al. ImmunoPET imaging of endogenous and transfected prolactin receptor tumor xenografts. Molecular Pharmaceutics. PMID 29684277 DOI: 10.1021/Acs.Molpharmaceut.7B01133 |
0.407 |
|
| 2018 |
Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, et al. Reproducibility and repeatability of semi-quantitativeF-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant prostate cancer metastases: a prospective multi-center study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29626121 DOI: 10.2967/Jnumed.117.206490 |
0.323 |
|
| 2018 |
Kirov AS, Fanchon LM, Seiter D, Czmielewski C, Russell J, Dogan S, Carlin S, Pinker-Domenig K, Yorke E, Schmidtlein CR, Boyko V, Fujisawa S, Manova-Todorova K, Zanzonico P, Dauer L, et al. Technical Note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activityF-FDG injection. Medical Physics. PMID 29480927 DOI: 10.1002/Mp.12836 |
0.306 |
|
| 2018 |
Dunphy MPS, Harding JJ, Venneti S, Zhang H, Burnazi EM, Bromberg J, Omuro AM, Hsieh JJ, Mellinghoff IK, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Gerecitano JF, Kelsen DP, et al. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R )-4-Fluoroglutamine. Radiology. 162610. PMID 29388903 DOI: 10.1148/Radiol.2017162610 |
0.413 |
|
| 2018 |
Bailey K, Pandit-Taskar N, Humm J, Zanzonico P, Gilheeney SW, Kramer K. Embr-03. Treatment Of Embryonal Tumor With Multilayered Rosettes (Etmr) With Targeted Radioimmunotherapy Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.188 |
0.342 |
|
| 2017 |
Ulaner GA, Lyashchenko SK, Riedl C, Ruan S, Zanzonico PB, Lake D, Jhaveri K, Zeglis B, Lewis JS, O'Donoghue JA. First-in-human HER2-targeted imaging using (89)Zr-pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29146695 DOI: 10.2967/Jnumed.117.202010 |
0.357 |
|
| 2017 |
Chen F, Ma K, Zhang L, Madajewski B, Zanzonico P, Sequeira S, Gonen M, Wiesner U, Bradbury MS. Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies. Chemistry of Materials : a Publication of the American Chemical Society. 29: 8269-8281. PMID 29123332 DOI: 10.1021/Acs.Chemmater.7B02567 |
0.362 |
|
| 2017 |
Chen F, Zhang X, Ma K, Madajewski B, Benezra M, Zhang L, Phillips E, Turker MZ, Gallazzi F, Overholtzer M, Pauliah M, Gonen M, Zanzonico P, Wiesner UB, Bradbury MS, et al. Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging. Acs Applied Materials & Interfaces. PMID 29058865 DOI: 10.1021/Acsami.7B14362 |
0.359 |
|
| 2017 |
Pandit-Taskar N, Zanzonico P, Hilden P, Ostrovnaya I, Carrasquillo JA, Modak S. Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging. Clinical Nuclear Medicine. 42: 741-748. PMID 28759518 DOI: 10.1097/Rlu.0000000000001752 |
0.305 |
|
| 2017 |
Cheal SM, Fung EK, Patel MV, Punzalan B, Xu H, Guo HF, Zanzonico PB, Monette S, Wittrup KD, Cheung NK, Larson SM. Curative multi-cycle radioimmunotherapy monitored by quantitative SPECT/CT-based theranostics, using bispecific antibody pretargeting strategy in colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28705917 DOI: 10.2967/Jnumed.117.193250 |
0.408 |
|
| 2017 |
Pandit-Taskar N, Zanzonico PB, Staton KD, Carrasquillo JA, Reidy-Lagunes D, Lyashchenko SK, Burnazi E, Zhang H, Lewis JS, Blasberg R, Larson SM, Weber WA, Modak S. Biodistribution and dosimetry of (18)F-Meta Fluorobenzyl Guanidine (MFBG): A first-in-human PET-CT imaging study of patients with neuroendocrine malignancies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28705916 DOI: 10.2967/Jnumed.117.193169 |
0.394 |
|
| 2017 |
O'Donoghue JA, Lewis JS, Pandit-Taskar N, Fleming SE, Schoder H, Larson SM, Beylergil V, Ruan S, Lyashchenko S, Zanzonico PB, Weber WA, Carrasquillo JA, Janjigian YY. Pharmacokinetics, biodistribution, and radiation dosimetry for (89)Zr-trastuzumab in patients with esophagogastric cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28637800 DOI: 10.2967/Jnumed.117.194555 |
0.408 |
|
| 2017 |
Schwartz J, Grkovski M, Rimner A, Schoder H, Zanzonico PB, Carlin SD, Staton KD, Humm JL, Nehmeh SA. Pharmacokinetic Analysis of Dynamic (18)F-FMISO PET Data in Non-small Cell Lung Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28232611 DOI: 10.2967/Jnumed.116.180422 |
0.359 |
|
| 2017 |
Houghton JL, Membreno R, Abdel-Atti D, Cunanan KM, Carlin S, Scholz WW, Zanzonico PB, Lewis JS, Zeglis BM. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry. Molecular Cancer Therapeutics. 16: 124-133. PMID 28062708 DOI: 10.1158/1535-7163.Mct-16-0503 |
0.415 |
|
| 2017 |
Souweidane MM, Kramer K, Pandit-Taskar N, Zanzonico P, Zhou Z, Donzelli M, Lyashchenko SK, Haque S, Thakur SB, Cheung NV, Larson SM, Dunkel IJ. A phase I study of convection enhanced delivery (CED) of 124I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma (DIPG). Journal of Clinical Oncology. 35: 2010-2010. DOI: 10.1200/Jco.2017.35.15_Suppl.2010 |
0.335 |
|
| 2017 |
Kramer K, Kushner BH, Modak S, Pandit-Taskar N, Tomlinson U, Wolden SL, Zanzonico P, John HL, Haque S, Souweidane MM, Greenfield J, Basu EM, Roberts SS, Carrasquillo JA, Lewis JS, et al. A curative approach to central nervous system metastases of neuroblastoma. Journal of Clinical Oncology. 35: 10545-10545. DOI: 10.1200/Jco.2017.35.15_Suppl.10545 |
0.306 |
|
| 2017 |
Kramer K, Kushner B, Modak S, Pandit-Taskar N, Tomlinson U, Donzelli M, Wolden S, Zanzonico P, Humm J, Haque S, Souweidane M, Greenfield J, Basu E, Roberts S, Carrasquillo J, et al. SCDT-38. SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE Neuro-Oncology. 19: vi272-vi272. DOI: 10.1093/Neuonc/Nox168.1119 |
0.364 |
|
| 2016 |
Cho H, Ackerstaff E, Carlin S, Lupu ME, Wang Y, Rizwan A, O'Donoghue J, Ling CC, Humm JL, Zanzonico PB, Koutcher JA. Corrigendum to "Noninvasive Multimodality Imaging of the Tumor Microenvironment: Registered Dynamic Magnetic Resonance Imaging and Positron Emission Tomography Studies of a Preclinical Tumor Model of Tumor Hypoxia" [Neoplasia 11 (2009) 247-259]. Neoplasia (New York, N.Y.). 18: 811. PMID 27978998 DOI: 10.1016/J.Neo.2016.10.008 |
0.394 |
|
| 2016 |
Zanzonico P, Dauer L, Strauss HW. Radiobiology in Cardiovascular Imaging. Jacc-Cardiovascular Imaging. 9: 1446-1461. PMID 27931527 DOI: 10.1016/J.Jcmg.2016.09.012 |
0.349 |
|
| 2016 |
Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA. Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer. Ejnmmi Research. 6: 79. PMID 27822900 DOI: 10.1186/S13550-016-0210-Y |
0.337 |
|
| 2016 |
Fung EK, Cheal SM, Fareedy SB, Punzalan B, Beylergil V, Amir J, Chalasani S, Weber WA, Spratt DE, Veach DR, Bander NH, Larson SM, Zanzonico PB, Osborne JR. Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling. Ejnmmi Research. 6: 7. PMID 26801327 DOI: 10.1186/S13550-016-0164-0 |
0.395 |
|
| 2015 |
Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA. Feasibility of 18F-fluoromisonidazole kinetic modeling in head and neck cancer using shortened acquisition times. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26609178 DOI: 10.2967/Jnumed.115.160168 |
0.307 |
|
| 2015 |
Cheal SM, Xu H, Guo HF, Lee SG, Punzalan B, Chalasani S, Fung EK, Jungbluth A, Zanzonico PB, Carrasquillo JA, O'Donoghue J, Smith-Jones PM, Wittrup KD, Cheung NV, Larson SM. Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity (86)Y- or (177)Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26596724 DOI: 10.1007/S00259-015-3254-8 |
0.337 |
|
| 2015 |
Thorek DL, Kramer RM, Chen Q, Jeong J, Lupu ME, Lee AM, Moynahan ME, Lowery M, Ulmert D, Zanzonico P, Deasy JO, Humm JL, Russell J. Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models. International Journal of Radiation Oncology, Biology, Physics. PMID 26238952 DOI: 10.1016/J.Ijrobp.2015.06.001 |
0.396 |
|
| 2015 |
Zanzonico P, Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, Humm JL, Smith-Jones P, Ruan S, Divgi C, Scott AM, Kemeny NE, Fong Y, Wong D, Scheinberg D, Ritter G, Jungbluth A, et al. PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1700-6. PMID 26194713 DOI: 10.1007/S00259-015-3061-2 |
0.379 |
|
| 2015 |
Kramer K, Pandit-Taskar N, Zanzonico P, Wolden SL, Humm JL, DeSelm C, Souweidane MM, Lewis JS, Cheung NK. Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy. Journal of Neuro-Oncology. 123: 245-9. PMID 25944385 DOI: 10.1007/S11060-015-1788-Z |
0.316 |
|
| 2015 |
Lohrmann C, Zhang H, Thorek DL, Desai P, Zanzonico PB, O'Donoghue J, Irwin CP, Reiner T, Grimm J, Weber WA. Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 805-11. PMID 25840974 DOI: 10.2967/Jnumed.114.149054 |
0.332 |
|
| 2015 |
Dunphy M, Harding JJ, Lewis JS, Mellinghoff IK, Omuro AMP, Hsieh J, Zhang H, Zanzonico P, Venneti S, Carlin S, Younes A, Gerecitano JF, Lyashchenko SK, Harris L, Lashley A, et al. Phenotypic correlation of tumor uptake of exogenous glutamine radiotracer versus tumor mutational status. Journal of Clinical Oncology. 33: 11014-11014. DOI: 10.1200/Jco.2015.33.15_Suppl.11014 |
0.399 |
|
| 2015 |
Taldone T, Pillarsetty N, Dunphy MP, Gerecitano JF, Caldas-Lopes E, Beattie B, Peter RI, Kang Y, Rodina A, Yan P, Gomes EMD, Bolaender A, Pressl C, Punzalan B, Ku A, ... ... Zanzonico P, et al. Abstract 5444: Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy Cancer Research. 75: 5444-5444. DOI: 10.1158/1538-7445.Am2015-5444 |
0.406 |
|
| 2014 |
Fung EK, Cheal SM, Chalasani S, Fareedy SB, Otto B, Punzalan B, Humm JL, Bander NH, Osborne JR, Larson SM, Zanzonico PB. TU-F-12A-01: Quantitative Non-Linear Compartment Modeling of 89Zr- and 124I- Labeled J591 Monoclonal Antibody Kinetics Using Serial Non-Invasive Positron Emission Tomography Imaging in a Pre-Clinical Human Prostate Cancer Mouse Model. Medical Physics. 41: 480. PMID 28036735 DOI: 10.1118/1.4889356 |
0.337 |
|
| 2014 |
Gholami S, Marano A, Chen NG, Aguilar RJ, Frentzen A, Chen CH, Lou E, Fujisawa S, Eveno C, Belin L, Zanzonico P, Szalay A, Fong Y. A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer. Breast Cancer Research and Treatment. 148: 489-99. PMID 25391896 DOI: 10.1007/S10549-014-3180-7 |
0.319 |
|
| 2014 |
Phillips E, Penate-Medina O, Zanzonico PB, Carvajal RD, Mohan P, Ye Y, Humm J, Gönen M, Kalaigian H, Schöder H, Strauss HW, Larson SM, Wiesner U, Bradbury MS. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Science Translational Medicine. 6: 260ra149. PMID 25355699 DOI: 10.1126/Scitranslmed.3009524 |
0.357 |
|
| 2014 |
Cheal SM, Xu H, Guo HF, Zanzonico PB, Larson SM, Cheung NK. Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex. Molecular Cancer Therapeutics. 13: 1803-12. PMID 24944121 DOI: 10.1158/1535-7163.Mct-13-0933 |
0.408 |
|
| 2014 |
Cheal SM, Punzalan B, Doran MG, Evans MJ, Osborne JR, Lewis JS, Zanzonico P, Larson SM. Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 41: 985-94. PMID 24604591 DOI: 10.1007/S00259-013-2679-1 |
0.357 |
|
| 2014 |
Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2182-91. PMID 24573553 DOI: 10.1158/1078-0432.Ccr-13-1153 |
0.358 |
|
| 2014 |
Luther N, Zhou Z, Zanzonico P, Cheung NK, Humm J, Edgar MA, Souweidane MM. The potential of theragnostic ¹²â´I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma. Neuro-Oncology. 16: 800-6. PMID 24526309 DOI: 10.1093/Neuonc/Not298 |
0.33 |
|
| 2014 |
Jun KH, Gholami S, Song TJ, Au J, Haddad D, Carson J, Chen CH, Mojica K, Zanzonico P, Chen NG, Zhang Q, Szalay A, Fong Y. A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter Journal of Experimental and Clinical Cancer Research. 33. PMID 24383569 DOI: 10.1186/1756-9966-33-2 |
0.378 |
|
| 2014 |
Cheal SM, Yoo B, Boughdad S, Punzalan B, Yang G, Dilhas A, Torchon G, Pu J, Axworthy DB, Zanzonico P, Ouerfelli O, Larson SM. Evaluation of glycodendron and synthetically modified dextran clearing agents for multistep targeting of radioisotopes for molecular imaging and radioimmunotherapy. Molecular Pharmaceutics. 11: 400-16. PMID 24219178 DOI: 10.1021/Mp4003128 |
0.347 |
|
| 2014 |
Gholami S, Chen CH, Lou E, Belin LJ, Fujisawa S, Longo VA, Chen NG, Gönen M, Zanzonico PB, Szalay AA, Fong Y. Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 676-82. PMID 24186964 DOI: 10.1096/Fj.13-237222 |
0.312 |
|
| 2014 |
Carrasquillo JA, Danila DC, Beylergil V, O'Donoghue JA, Cheal SM, Ruan S, Pandit-Taskar N, Fox JJ, Fleming SE, Zanzonico PB, Ragupathi G, Lyashchenko SK, William SP, Larson SM, Scher HI, et al. Abstract 2069: Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients Cancer Research. 74: 2069-2069. DOI: 10.1158/1538-7445.Am2014-2069 |
0.422 |
|
| 2014 |
Lanning R, Beattie B, Humm J, Zanzonico P, Rao S, Romesser P, Wong R, Sherman E, Schoder H, Lee N. Preliminary Results of a Prospective Trial of IMRT Dose De-escalation to Gross Nodal Disease in Human Papillomavirus (HPV)-Positive Oropharyngeal Carcinoma (OPC) Based on Assessment of Tumor Hypoxia Using 18F-FMISO PET Imaging International Journal of Radiation Oncology*Biology*Physics. 88: 474. DOI: 10.1016/J.Ijrobp.2013.11.044 |
0.347 |
|
| 2013 |
Emmetiere F, Irwin C, Viola-Villegas NT, Longo V, Cheal SM, Zanzonico P, Pillarsetty N, Weber WA, Lewis JS, Reiner T. (18)F-labeled-bioorthogonal liposomes for in vivo targeting. Bioconjugate Chemistry. 24: 1784-9. PMID 24180480 DOI: 10.1021/Bc400322H |
0.392 |
|
| 2013 |
Dewaraja YK, Ljungberg M, Green AJ, Zanzonico PB, Frey EC, Bolch WE, Brill AB, Dunphy M, Fisher DR, Howell RW, Meredith RF, Sgouros G, Wessels BW. MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 2182-8. PMID 24130233 DOI: 10.2967/Jnumed.113.122390 |
0.671 |
|
| 2013 |
Belin LJ, Ady JW, Lewis C, Marano D, Gholami S, Mojica K, Eveno C, Longo V, Zanzonico PB, Chen NG, Szalay AA, Fong Y. An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma. Surgery. 154: 486-95. PMID 23890748 DOI: 10.1016/j.surg.2013.06.004 |
0.316 |
|
| 2013 |
O'Donoghue JA, Guillem JG, Schöder H, Lee NY, Divgi CR, Ruby JA, Humm JL, Lee-Kong SA, Burnazi EM, Cai S, Carlin SD, Leibold T, Zanzonico PB, Ling CC. Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer. Ejnmmi Research. 3: 42. PMID 23731770 DOI: 10.1186/2191-219X-3-42 |
0.388 |
|
| 2013 |
Stelter L, Fuchs S, Jungbluth AA, Ritter G, Longo VA, Zanzonico P, Raschzok N, Sauer IM, Bomalaski JS, Larson SM. Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 768-75. PMID 23722880 DOI: 10.1007/S11307-013-0655-6 |
0.307 |
|
| 2013 |
Xing L, Sun X, Deng X, Kotedia K, Zanzonico PB, Ackerstaff E, Koutcher JA, Ling CC, Li GC. A triple suicide gene strategy that improves therapeutic effects and incorporates multimodality molecular imaging for monitoring gene functions Cancer Gene Therapy. 20: 358-365. PMID 23722591 DOI: 10.1038/Cgt.2013.28 |
0.302 |
|
| 2013 |
Zeglis BM, Sevak KK, Reiner T, Mohindra P, Carlin SD, Zanzonico P, Weissleder R, Lewis JS. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1389-96. PMID 23708196 DOI: 10.2967/Jnumed.112.115840 |
0.397 |
|
| 2013 |
Gholami S, Chen CH, Belin LJ, Lou E, Fujisawa S, Antonacci C, Carew A, Chen NG, De Brot M, Zanzonico PB, Szalay AA, Fong Y. Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer. Breast Cancer Research : Bcr. 15: R26. PMID 23506710 DOI: 10.1186/Bcr3404 |
0.346 |
|
| 2013 |
Ho AL, Grewal RK, Leboeuf R, Sherman EJ, Pfister DG, Deandreis D, Pentlow KS, Zanzonico PB, Haque S, Gavane S, Ghossein RA, Ricarte-Filho JC, Domínguez JM, Shen R, Tuttle RM, et al. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. The New England Journal of Medicine. 368: 623-32. PMID 23406027 DOI: 10.1056/Nejmoa1209288 |
0.313 |
|
| 2013 |
Stelter L, Evans MJ, Jungbluth AA, Longo VA, Zanzonico P, Ritter G, Bomalaski JS, Old L, Larson SM. Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma. Molecular Imaging. 12: 67-73. PMID 23348793 DOI: 10.2310/7290.2012.00009 |
0.383 |
|
| 2013 |
Stelter L, Tseng JC, Torosjan A, Levin B, Longo VA, Pillarsetty N, Zanzonico P, Meruelo D, Larson SM. Tumor-specific targeting with modified Sindbis viral vectors: evaluation with optical imaging and positron emission tomography in vivo. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 166-74. PMID 22847302 DOI: 10.1007/S11307-012-0585-8 |
0.359 |
|
| 2013 |
Slovin SF, Wang X, Hullings M, Arauz G, Bartido S, Lewis JS, Schöder H, Zanzonico P, Scher HI, Riviere I. Chimeric antigen receptor (CAR+) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC). Journal of Clinical Oncology. 31: 72-72. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps3115 |
0.334 |
|
| 2013 |
Modak S, Quaglia MPL, Carrasquillo JA, Zanzonico P, Enero C, Pandit-Taskar N, Kang HJ, Cheung NV. Intraperitoneal radioimmunotherapy (RIT) for desmoplastic small round cell tumor (DSRCT): Initial results from a phase I trial. Journal of Clinical Oncology. 31: 3033-3033. DOI: 10.1200/Jco.2013.31.15_Suppl.3033 |
0.358 |
|
| 2012 |
Stoyanova R, Huang K, Sandler K, Cho H, Carlin S, Zanzonico PB, Koutcher JA, Ackerstaff E. Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data. Translational Oncology. 5: 437-47. PMID 23326621 DOI: 10.1593/Tlo.12319 |
0.381 |
|
| 2012 |
Benezra M, Hambardzumyan D, Penate-Medina O, Veach DR, Pillarsetty N, Smith-Jones P, Phillips E, Ozawa T, Zanzonico PB, Longo V, Holland EC, Larson SM, Bradbury MS. Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma model. Neoplasia (New York, N.Y.). 14: 1132-43. PMID 23308046 DOI: 10.1593/Neo.121750 |
0.401 |
|
| 2012 |
Haddad D, Zanzonico PB, Carlin S, Chen CH, Chen NG, Zhang Q, Yu YA, Longo V, Mojica K, Aguilar RJ, Szalay AA, Fong Y. A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1933-42. PMID 23139088 DOI: 10.2967/Jnumed.112.105056 |
0.349 |
|
| 2012 |
Sgouros G, Zanzonico P. Humm recognized with Loevinger-Berman Award. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 20N. PMID 23124873 |
0.563 |
|
| 2012 |
Bartlett RM, Beattie BJ, Naryanan M, Georgi JC, Chen Q, Carlin SD, Roble G, Zanzonico PB, Gonen M, O'Donoghue J, Fischer A, Humm JL. Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1608-15. PMID 22933821 DOI: 10.2967/Jnumed.112.103523 |
0.375 |
|
| 2012 |
Haddad D, Chen CH, Carlin S, Silberhumer G, Chen NG, Zhang Q, Longo V, Carpenter SG, Mittra A, Carson J, Au J, Gonen M, Zanzonico PB, Szalay AA, Fong Y. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter. Plos One. 7: e41647. PMID 22912675 DOI: 10.1371/Journal.Pone.0041647 |
0.362 |
|
| 2012 |
Thorek DL, Abou DS, Beattie BJ, Bartlett RM, Huang R, Zanzonico PB, Grimm J. Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1438-45. PMID 22872741 DOI: 10.2967/Jnumed.112.104349 |
0.318 |
|
| 2012 |
Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB, Ljungberg M. MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1310-25. PMID 22743252 DOI: 10.2967/Jnumed.111.100123 |
0.672 |
|
| 2012 |
Zanzonico P. Principles of nuclear medicine imaging: planar, SPECT, PET, multi-modality, and autoradiography systems. Radiation Research. 177: 349-364. PMID 22364319 DOI: 10.1667/Rr2577.1 |
0.352 |
|
| 2012 |
Dunphy MP, Zanzonico P, Veach D, Somwar R, Pillarsetty N, Lewis J, Larson S. Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 25-31. PMID 21161687 DOI: 10.1007/S11307-010-0462-2 |
0.392 |
|
| 2012 |
Wang K, Georgi J, Zanzonico P, Narayanan M, Paulus T, Bal M, Wang W, Cai S, O’Donoghue J, Ling CC, Humm JL. Hypoxia Imaging of Rodent Xenografts with 18F-Fluoromisonidazole: Comparison of Dynamic and Static PET Imaging International Journal of Medical Physics, Clinical Engineering and Radiation Oncology. 1: 95-104. DOI: 10.4236/Ijmpcero.2012.13013 |
0.412 |
|
| 2012 |
Modak S, Carrasquillo JA, La Quaglia MP, Zanzonico P, Pandit-Taskar N, Lewis JS, Cheung NV. Intraperitoneal radioimmunotherapy (RIT) for desmoplastic small round cell tumor (DSRCT). Journal of Clinical Oncology. 30: TPS9595-TPS9595. DOI: 10.1200/Jco.2012.30.15_Suppl.Tps9595 |
0.392 |
|
| 2012 |
Gholami S, Chen C, Lou E, Marano AA, Mojica KM, Chen NG, Aguilar RJ, Belin LJ, Longo VA, Zanzonico P, Szalay AA, Fong Y. Abstract 5660: Vaccinia virus GLV-1h153 in combination with131I-iodine shows increased efficiency in treating triple-negative breast cancerin vivo Cancer Research. 72: 5660-5660. DOI: 10.1158/1538-7445.Am2012-5660 |
0.345 |
|
| 2012 |
Belin LJ, Gholami S, Mojica KM, Marano AA, Zanzonico PB, Longo VA, Chen NG, Aguilar RJ, Szalay AA, Fong Y. GLV1h153, an oncolytic vaccinia virus carrying the human sodium iodide symporter, kills malignant pleural mesothelioma and facilitates PET imaging Journal of the American College of Surgeons. 215: S136. DOI: 10.1016/J.Jamcollsurg.2012.06.351 |
0.339 |
|
| 2011 |
Zanzonico P. Basic Sciences of Nuclear Medicine Medical Physics. 38: 5265-5266. PMID 28524975 DOI: 10.1118/1.3626488 |
0.357 |
|
| 2011 |
Chakravarty D, Santos E, Ryder M, Knauf JA, Liao XH, West BL, Bollag G, Kolesnick R, Thin TH, Rosen N, Zanzonico P, Larson SM, Refetoff S, Ghossein R, Fagin JA. Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. The Journal of Clinical Investigation. 121: 4700-11. PMID 22105174 DOI: 10.1172/Jci46382 |
0.308 |
|
| 2011 |
Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, Humm JL, Zanzonico P, Smith-Jones PM, Divgi CR, Pryma DA, Ruan S, Kemeny NE, Fong Y, Wong D, Jaggi JS, Scheinberg DA, Gonen M, et al. (124)I-huA33 antibody PET of colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1173-80. PMID 21764796 DOI: 10.2967/Jnumed.110.086165 |
0.319 |
|
| 2011 |
Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A, DeStanchina E, Longo V, Herz E, Iyer S, Wolchok J, Larson SM, Wiesner U, Bradbury MS. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. The Journal of Clinical Investigation. 121: 2768-80. PMID 21670497 DOI: 10.1172/Jci45600 |
0.381 |
|
| 2011 |
Haddad D, Chen NG, Zhang Q, Chen CH, Yu YA, Gonzalez L, Carpenter SG, Carson J, Au J, Mittra A, Gonen M, Zanzonico PB, Fong Y, Szalay AA. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus. Journal of Translational Medicine. 9: 36. PMID 21453532 DOI: 10.1186/1479-5876-9-36 |
0.377 |
|
| 2011 |
Medina OP, Pillarsetty N, Glekas A, Punzalan B, Longo V, Gönen M, Zanzonico P, Smith-Jones P, Larson SM. Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system. Journal of Controlled Release : Official Journal of the Controlled Release Society. 149: 292-8. PMID 21047536 DOI: 10.1016/J.Jconrel.2010.10.024 |
0.387 |
|
| 2011 |
Haddad D, Szalay AA, Fong Y, Zanzonico PB, Carlin S, Chen C, Chen NG, Zhang Q, Yu YA, Longo V, Mojica K. Abstract PR7: An oncolytic vaccinia virus encoding the human sodium iodide symporter facilitates long-term deep-tissue image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-Pr7 |
0.329 |
|
| 2010 |
Zanzonico P. Nuclear Medicine Physics. Medical Physics. 38: 4904-4904. PMID 28525164 DOI: 10.1118/1.3611048 |
0.328 |
|
| 2010 |
Sgouros G, Roeske JC, McDevitt MR, Palm S, Allen BJ, Fisher DR, Brill AB, Song H, Howell RW, Akabani G, Bolch WE, Brill AB, Fisher DR, Howell RW, ... ... Zanzonico PB, et al. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 311-28. PMID 20080889 DOI: 10.2967/Jnumed.108.058651 |
0.621 |
|
| 2010 |
Beattie BJ, Smith-Jones PM, Jhanwar YS, Schöder H, Schmidtlein CR, Morris MJ, Zanzonico P, Squire O, Meirelles GS, Finn R, Namavari M, Cai S, Scher HI, Larson SM, Humm JL. Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 183-92. PMID 20080885 DOI: 10.2967/Jnumed.109.066159 |
0.313 |
|
| 2010 |
Sofou S, Enmon R, Palm S, Kappel B, Zanzonico P, McDevitt MR, Scheinberg DA, Sgouros G. Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer. Journal of Liposome Research. 20: 330-40. PMID 20070139 DOI: 10.3109/08982100903544185 |
0.743 |
|
| 2010 |
Ruggiero A, Brader P, Serganova I, Zanzonico P, Cai S, Lipman NS, Hricak H, Blasberg RG. Different Strategies for Reducing Intestinal Background Radioactivity Associated with Imaging HSV1- tk Expression Using Established Radionucleoside Probes Molecular Imaging. 9: 47-58. DOI: 10.2310/7290.2010.00006 |
0.31 |
|
| 2010 |
Benezra M, Hambardzumyan D, Penate-Medina O, Veach DR, Pillarsetty N, Smith-Jones P, Zanzonico P, Longo VA, Holland EC, Larson SM, Bradbury MS. Abstract LB-299: F-dasatinib inhibits glioma cell proliferation and alters expression of PDGFR signaling pathway intermediates in PDGFR-overexpressing glioma models Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-299 |
0.367 |
|
| 2010 |
He P, Kramer K, Smith-Jones P, Zanzonico P, Humm J, Larson SM, Cheung NV. Abstract 5633: Two-compartment pharmacokinetics model of radioimmunotherapy with131I-3F8 directly administered into the cerebrospinal fluid Cancer Research. 70: 5633-5633. DOI: 10.1158/1538-7445.Am10-5633 |
0.349 |
|
| 2009 |
Chang J, Wen B, Kazanzides P, Zanzonico P, Finn RD, Fichtinger G, Ling CC. A robotic system for 18F-FMISO PET-guided intratumoral pO2 measurements. Medical Physics. 36: 5301-9. PMID 19994538 DOI: 10.1118/1.3239491 |
0.389 |
|
| 2009 |
Brader P, Kelly KJ, Chen N, Yu YA, Zhang Q, Zanzonico P, Burnazi EM, Ghani RE, Serganova I, Hricak H, Szalay AA, Fong Y, Blasberg RG. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3791-801. PMID 19470726 DOI: 10.1158/1078-0432.Ccr-08-3236 |
0.415 |
|
| 2009 |
Wang W, Georgi JC, Nehmeh SA, Narayanan M, Paulus T, Bal M, O'Donoghue J, Zanzonico PB, Schmidtlein CR, Lee NY, Humm JL. Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging. Physics in Medicine and Biology. 54: 3083-99. PMID 19420418 DOI: 10.1088/0031-9155/54/10/008 |
0.339 |
|
| 2009 |
Cho H, Ackerstaff E, Carlin S, Lupu ME, Wang Y, Rizwan A, O'Donoghue J, Ling CC, Humm JL, Zanzonico PB, Koutcher JA. Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia. Neoplasia (New York, N.Y.). 11: 247-59, 2p following. PMID 19242606 DOI: 10.1593/Neo.81360 |
0.403 |
|
| 2009 |
Oehler C, O'Donoghue J, Zanzonico P, Russell J, Ling C, Carlin S. Use of 18F-MISO PET Imaging to Monitor the Response of Colorectal Xenografts to DMXAA International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1225 |
0.322 |
|
| 2008 |
He F, Deng X, Wen B, Liu Y, Sun X, Xing L, Minami A, Huang Y, Chen Q, Zanzonico PB, Ling CC, Li GC. Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers. Cancer Research. 68: 8597-606. PMID 18922936 DOI: 10.1158/0008-5472.Can-08-0677 |
0.383 |
|
| 2008 |
Zhang M, Huang M, Le C, Zanzonico PB, Claus F, Kolbert KS, Martin K, Ling CC, Koutcher JA, Humm JL. Accuracy and reproducibility of tumor positioning during prolonged and multi-modality animal imaging studies. Physics in Medicine and Biology. 53: 5867-82. PMID 18827321 DOI: 10.1088/0031-9155/53/20/021 |
0.399 |
|
| 2008 |
Riedl CC, Brader P, Zanzonico PB, Chun YS, Woo Y, Singh P, Carlin S, Wen B, Ling CC, Hricak H, Fong Y. Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology. 248: 561-70. PMID 18641253 DOI: 10.1148/Radiol.2482071421 |
0.367 |
|
| 2008 |
Zhang M, Chen Q, Li XF, O'Donoghue J, Ruan S, Zanzonico P, Ling CC, Humm JL. Image deconvolution in digital autoradiography: a preliminary study. Medical Physics. 35: 522-30. PMID 18383673 DOI: 10.1118/1.2828198 |
0.356 |
|
| 2008 |
Brader P, Stritzker J, Riedl CC, Zanzonico P, Cai S, Burnazi EM, Ghani ER, Hricak H, Szalay AA, Fong Y, Blasberg R. Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2295-302. PMID 18369089 DOI: 10.1158/1078-0432.Ccr-07-4254 |
0.417 |
|
| 2008 |
Bradbury MS, Hambardzumyan D, Zanzonico PB, Schwartz J, Cai S, Burnazi EM, Longo V, Larson SM, Holland EC. Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 422-9. PMID 18287265 DOI: 10.2967/Jnumed.107.047092 |
0.37 |
|
| 2008 |
Bernal P, Raoul JL, Stare J, Sereegotov E, Sundram FX, Kumar A, Jeong JM, Pusuwan P, Divgi C, Zanzonico P, Vidmar G, Buscombe J, Chau TT, Saw MM, Chen S, et al. International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study. Seminars in Nuclear Medicine. 38: S40-5. PMID 18243842 DOI: 10.1053/J.Semnuclmed.2007.10.006 |
0.315 |
|
| 2008 |
Zanzonico PB, Divgi C. Patient-specific radiation dosimetry for radionuclide therapy of liver tumors with intrahepatic artery rhenium-188 lipiodol. Seminars in Nuclear Medicine. 38: S30-9. PMID 18243841 DOI: 10.1053/J.Semnuclmed.2007.10.005 |
0.341 |
|
| 2008 |
Nehmeh SA, Lee NY, Schröder H, Squire O, Zanzonico PB, Erdi YE, Greco C, Mageras G, Pham HS, Larson SM, Ling CC, Humm JL. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. International Journal of Radiation Oncology, Biology, Physics. 70: 235-42. PMID 18086391 DOI: 10.1016/J.Ijrobp.2007.08.036 |
0.336 |
|
| 2008 |
Riedl CC, Brader P, Zanzonico P, Reid V, Woo Y, Wen B, Ling CC, Hricak H, Fong Y, Humm JL. Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort. European Journal of Nuclear Medicine and Molecular Imaging. 35: 39-46. PMID 17786438 DOI: 10.1007/S00259-007-0522-2 |
0.389 |
|
| 2008 |
Wang W, Georgi J, Nehmeh S, Narayanan M, Paulus T, O'Donoghue J, Zanzonico P, Schmidtlein C, Lee N, Humm J. TH‐C‐351‐06: Evaluation of a Compartmental Model for Estimating Tumor Hypoxia Via FMISO Dynamic PET Imaging Medical Physics. 35: 2975-2975. DOI: 10.1118/1.2962862 |
0.307 |
|
| 2008 |
Huang M, Zhang M, Chang J, Le C, Zanzonico P, Humm J, Koutcher J, Ling C. TU-D-332-08: Gd-DTPA DCE-MRI Assisted Image-Guided PO2 Measurements in Rodent Tumor Xenografts Medical Physics. 35: 2907-2907. DOI: 10.1118/1.2962599 |
0.347 |
|
| 2008 |
Huang M, Zhang M, Chang J, Le C, Zanzonico P, Humm J, Koutcher J, Ling C. TU-D-332-01: Mapping of Viable Tumor Regions Using Gd-DTPA DCE-MRI Medical Physics. 35: 2905-2906. DOI: 10.1118/1.2962592 |
0.413 |
|
| 2008 |
Zhang M, Huang M, Le C, Zanzonico P, Claus F, Kolbert K, Martin K, Ling C, Koutcher J, Humm J. TU-C-332-07: Accuracy and Reproducibility of Tumor Position During Prolonged and Multi-Modality Animal Imaging Studies Medical Physics. 35: 2895-2895. DOI: 10.1118/1.2962526 |
0.391 |
|
| 2007 |
Doubrovin MM, Doubrovina ES, Zanzonico P, Sadelain M, Larson SM, O'Reilly RJ. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Research. 67: 11959-69. PMID 18089827 DOI: 10.1158/0008-5472.Can-07-1250 |
0.375 |
|
| 2007 |
Kramer K, Humm JL, Souweidane MM, Zanzonico PB, Dunkel IJ, Gerald WL, Khakoo Y, Yeh SD, Yeung HW, Finn RD, Wolden SL, Larson SM, Cheung NK. Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5465-70. PMID 18048828 DOI: 10.1200/Jco.2007.11.1807 |
0.364 |
|
| 2007 |
Brader P, Riedl CC, Woo Y, Ponomarev V, Zanzonico P, Wen B, Cai S, Hricak H, Fong Y, Blasberg R, Serganova I. Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model. Molecular Cancer Therapeutics. 6: 2900-8. PMID 17989317 DOI: 10.1158/1535-7163.Mct-07-0432 |
0.384 |
|
| 2007 |
McDevitt MR, Chattopadhyay D, Jaggi JS, Finn RD, Zanzonico PB, Villa C, Rey D, Mendenhall J, Batt CA, Njardarson JT, Scheinberg DA. PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. Plos One. 2: e907. PMID 17878942 DOI: 10.1371/Journal.Pone.0000907 |
0.321 |
|
| 2007 |
Jaggi JS, Carrasquillo JA, Seshan SV, Zanzonico P, Henke E, Nagel A, Schwartz J, Beattie B, Kappel BJ, Chattopadhyay D, Xiao J, Sgouros G, Larson SM, Scheinberg DA. Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor. The Journal of Clinical Investigation. 117: 2422-30. PMID 17717602 DOI: 10.1172/Jci32226 |
0.713 |
|
| 2007 |
Bradbury MS, Panagiotakos G, Chan BK, Tomishima M, Zanzonico P, Vider J, Ponomarev V, Studer L, Tabar V. Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. Journal of Neurochemistry. 102: 2029-39. PMID 17555555 DOI: 10.1111/J.1471-4159.2007.04681.X |
0.304 |
|
| 2007 |
Moroz MA, Serganova I, Zanzonico P, Ageyeva L, Beresten T, Dyomina E, Burnazi E, Finn RD, Doubrovin M, Blasberg RG. Imaging hNET Reporter Gene Expression with 124I-MIBG The Journal of Nuclear Medicine. 48: 827-836. PMID 17475971 DOI: 10.2967/Jnumed.106.037812 |
0.353 |
|
| 2007 |
Beattie BJ, Förster GJ, Govantes R, Le CH, Longo VA, Zanzonico PB, Bidaut L, Blasberg RG, Koutcher JA. Multimodality registration without a dedicated multimodality scanner. Molecular Imaging. 6: 108-20. PMID 17445505 DOI: 10.2310/7290.2007.00008 |
0.341 |
|
| 2007 |
Kramer K, Modak S, Kushner BH, Souweidane M, Wolden S, Humm J, Zanzonico P, Smith-Jones P, Larson S, Cheung N. Metastatic neuroblastoma (NB) to the central nervous system (CNS): Improved outcome with combined modality including 131-I-8H9 or 131-I-3F8 radioimmunotherapy (RIT) delivered through the cerebrospinal fluid (CSF) Journal of Clinical Oncology. 25: 2022-2022. DOI: 10.1200/Jco.2007.25.18_Suppl.2022 |
0.321 |
|
| 2007 |
Jaggi JS, Carrasquillo JA, Seshan SV, Zanzonico P, Henke E, Nagel A, Schwartz J, Beattie B, Kappel BJ, Chattopadhyay D, Xiao J, Sgouros G, Larson SM, Scheinberg DA. Erratum: Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor (Journal of Clinical Investigation (2007) 117, (2422-2430) DOI: 10.1172/JCI32226)) Journal of Clinical Investigation. 117. DOI: 10.1172/Jci32226C1 |
0.672 |
|
| 2007 |
Zhang M, Chen Q, Li X, O'Donoghue J, Ruan S, Zanzonico P, Ling C, Humm J. SU‐FF‐I‐109: Image Deconvolution in Autoradiography: A Preliminary Study Medical Physics. 34: 2363-2363. DOI: 10.1118/1.2760486 |
0.345 |
|
| 2006 |
Zanzonico P, Koehne G, Gallardo HF, Doubrovin M, Doubrovina E, Finn R, Blasberg RG, Riviere I, O'Reilly RJ, Sadelain M, Larson SM. [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity. European Journal of Nuclear Medicine and Molecular Imaging. 33: 988-97. PMID 16607546 DOI: 10.1007/S00259-005-0057-3 |
0.335 |
|
| 2006 |
Zanzonico P. PET-based biological imaging for radiation therapy treatment planning. Critical Reviews in Eukaryotic Gene Expression. 16: 61-102. PMID 16584383 DOI: 10.1615/Critreveukargeneexpr.V16.I1.50 |
0.382 |
|
| 2006 |
Zanzonico P, Campa J, Polycarpe-Holman D, Forster G, Finn R, Larson S, Humm J, Ling C. Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors Nuclear Medicine and Biology. 33: 65-70. PMID 16459260 DOI: 10.1016/J.Nucmedbio.2005.07.011 |
0.397 |
|
| 2006 |
Chang J, Wen B, Kazanzides P, Zanzonico P, Finn R, Ling C. WE-D-330A-03: PO2 Measurements in Animal Tumors Using An Image-Guided Robotic System Medical Physics. 33: 2240-2240. DOI: 10.1118/1.2241741 |
0.331 |
|
| 2006 |
He F, Huang Y, Wen B, Deng X, Zanzonico P, Chen Q, Finn R, Ling C, Li GC. 2630: A Preclinical Human Tumor Model for Non-Invasive Imaging of Hypoxia-Induced Gene Expression; Comparison of Endogenous and Exogenous Markers of Tumor Hypoxia International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.1044 |
0.373 |
|
| 2005 |
O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S, Lewis JS, Welch MJ, Ling CC, Humm JL. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. International Journal of Radiation Oncology, Biology, Physics. 61: 1493-502. PMID 15817355 DOI: 10.1016/J.Ijrobp.2004.12.057 |
0.374 |
|
| 2005 |
Che J, Doubrovin M, Serganova I, Ageyeva L, Zanzonico P, Blasberg R. hNIS-IRES-eGFP dual reporter gene imaging. Molecular Imaging. 4: 128. DOI: 10.1162/15353500200504193 |
0.333 |
|
| 2004 |
Wen B, Burgman P, Zanzonico P, O'donoghue J, Cai S, Finn R, Serganova I, Blasberg R, Gelovani J, Li GC, Ling CC. A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia. European Journal of Nuclear Medicine and Molecular Imaging. 31: 1530-8. PMID 15378285 DOI: 10.1007/S00259-004-1673-Z |
0.371 |
|
| 2004 |
Zanzonico P, O'Donoghue J, Chapman JD, Schneider R, Cai S, Larson S, Wen B, Chen Y, Finn R, Ruan S, Gerweck L, Humm J, Ling C. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning. European Journal of Nuclear Medicine and Molecular Imaging. 31: 117-28. PMID 14523586 DOI: 10.1007/S00259-003-1322-Y |
0.437 |
|
| 2003 |
Humm JL, Ballon D, Hu YC, Ruan S, Chui C, Tulipano PK, Erdi A, Koutcher J, Zakian K, Urano M, Zanzonico P, Mattis C, Dyke J, Chen Y, Harrington P, et al. A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography. Medical Physics. 30: 2303-14. PMID 14528951 DOI: 10.1118/1.1600738 |
0.4 |
|
| 2003 |
Palm S, Enmon RM, Matei C, Kolbert KS, Xu S, Zanzonico PB, Finn RL, Koutcher JA, Larson SM, Sgouros G. Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 44: 1148-55. PMID 12843231 |
0.626 |
|
| 2003 |
Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes Nature Biotechnology. 21: 405-413. PMID 12652311 DOI: 10.1038/Nbt805 |
0.365 |
|
| 2002 |
Urano M, Chen Y, Humm J, Koutcher JA, Zanzonico P, Ling C. Measurements of tumor tissue oxygen tension using a time-resolved luminescence-based optical oxylite probe: comparison with a paired survival assay. Radiation Research. 158: 167-73. PMID 12105986 DOI: 10.1667/0033-7587(2002)158[0167:Mottot]2.0.Co;2 |
0.346 |
|
| 2002 |
Ugur Ö, Kothari PJ, Finn RD, Zanzonico P, Ruan S, Guenther I, Maecke HR, Larson SM. Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. Nuclear Medicine and Biology. 29: 147-157. PMID 11823119 DOI: 10.1016/S0969-8051(01)00290-6 |
0.392 |
|
| 1987 |
Welt S, Mattes MJ, Grando R, Thomson TM, Leonard RW, Zanzonico PB, Bigler RE, Yeh S, Oettgen HF, Old LJ. Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu mice Proceedings of the National Academy of Sciences of the United States of America. 84: 4200-4204. PMID 3473501 DOI: 10.1073/Pnas.84.12.4200 |
0.783 |
|
| 1985 |
Bigler RE, Zanzonico PB, Schmall B, Conti PS, Dahl JR, Rothman L, Sgouros G, MacEwen EG. Evaluation of [1-11C]-α-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies European Journal of Nuclear Medicine. 10: 48-55. PMID 3979410 DOI: 10.1007/Bf00261763 |
0.76 |
|
| 1984 |
Schmall B, Conti PS, Bigler RE, Zanzonico PB, Robert Dahl J, Sundoro-Wu BM, Jacobsen JK, Lee R. Synthesis and quality assurance of [11C]alpha-aminoisobutyric acid (AIB), a potential radiotracer for imaging and amino acid transport studies in normal and malignant tissues International Journal of Nuclear Medicine and Biology. 11: 209-214. PMID 6530341 DOI: 10.1016/0047-0740(84)90001-9 |
0.756 |
|
| 1981 |
Dunzendorfer U, Schmall B, Bigler RE, Zanzonico PB, Conti PS, Dahl JR, Kleinert E, Whitmore WF. Synthesis and body distribution of alpha-aminoisobutyric acid-L-<sup>11</sup>C in normal and prostate cancer-bearing rat after chemotherapy European Journal of Nuclear Medicine. 6: 535-538. PMID 7327192 DOI: 10.1007/Bf00255888 |
0.758 |
|
| Show low-probability matches. |